Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Neurology|April 10, 2013
Evidence-based guideline: treatment of parenchymal neurocysticercosis [RETIRED]: report of the Guideline Development Subcommittee of the American Academy of NeurologyRuth Ann Baird, Sam Wiebe, Joseph R Zunt, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2024
Phage K exposure generates phage-neutralizing activity in a rabbit model-humoral receptiveness may impact efficacy of phage therapySebastian C Herren, Melissa J Karau, Christina A Koscianski, et al.
Journal of Clinical Microbiology|November 5, 2020
Serum Epitope Repertoire Analysis Enables Early Detection of Lyme Disease with Improved Sensitivity in an Expandable Multiplex FormatJack Reifert, Kathy Kamath, Joel Bozekowski, et al.
Journal of Clinical Microbiology|April 28, 2017
Serologic Testing for Zika Virus: Comparison of Three Zika Virus IgM-Screening Enzyme-Linked Immunosorbent Assays and Initial Laboratory ExperiencesDane Granger, Heather Hilgart, Lori Misner, et al.
The American Journal of Medicine|June 15, 2013
Treatment trials for post-Lyme disease symptoms revisitedMark S Klempner, Phillip J Baker, Eugene D Shapiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2015
Unorthodox alternative therapies marketed to treat Lyme diseasePaul M Lantos, Eugene D Shapiro, Paul G Auwaerter, et al.
JAMA Network Open|January 14, 2026
Lyme Disease and Health Care CostsHolly Yu, Rebecca M Fee, Brian T Campfield, et al.
Microbiology Spectrum|July 21, 2022
Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA ThresholdsNicholas E Larkey, Radwa Ewaisha, Michael A Lasho, et al.
Journal of Medical Ethics|November 25, 2010
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activismPaul G Auwaerter, Johan S Bakken, Raymond J Dattwyler, et al.
Frontiers in Immunology|February 14, 2022
Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting TherapyPaige K Marty, Virginia P Van Keulen, Courtney L Erskine, et al.
Pageof 8